Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Long-Term Deferred Tax came in at $952.0 million in Q2 2026, down 2.16% on a YoY basis from $973.0 million in Q2 2025, and up 0.74% quarter-over-quarter from $945.0 million in Q1 2026.
Analysis
Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has reported Long-Term Deferred Tax for 6 consecutive years, with $952.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Long-Term Deferred Tax fell 2.16% year-over-year to $952.0 million; the trailing twelve-month figure through Jun 2026 stood at $952.0 million (down 2.16% YoY), and the FY2025 full-year result was $934.0 million, up 5.54% from the prior year.
- Long-Term Deferred Tax rose to $952.0 million in Q2 2026 per BLCO's latest filing, from $945.0 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $1.0 billion in Q1 2022 and bottomed at $827.0 million in Q2 2024.
- Historically, Long-Term Deferred Tax has averaged $923.3 million across 5 years, with a median of $925.0 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax decreased 11.83% in 2024, then rose 17.65% in 2025.
- Over 5 years, Long-Term Deferred Tax stood at $927.0 million in 2022, then dropped by 0.65% to $921.0 million in 2023, then slipped by 3.91% to $885.0 million in 2024, then rose by 5.54% to $934.0 million in 2025, then rose by 1.93% to $952.0 million in 2026.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $952.0 million, $945.0 million, and $934.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 952.00 Mn |
| Mar 31, 2026 | 945.00 Mn |
| Dec 31, 2025 | 934.00 Mn |
| Sep 30, 2025 | 978.00 Mn |
| Jun 30, 2025 | 973.00 Mn |
| Mar 31, 2025 | 864.00 Mn |
| Dec 31, 2024 | 885.00 Mn |
| Sep 30, 2024 | 931.00 Mn |
| Jun 30, 2024 | 827.00 Mn |
| Mar 31, 2024 | 860.00 Mn |
| Dec 31, 2023 | 921.00 Mn |
| Sep 30, 2023 | 920.00 Mn |
| Jun 30, 2023 | 938.00 Mn |
| Mar 31, 2023 | 923.00 Mn |
| Dec 31, 2022 | 927.00 Mn |
| Sep 30, 2022 | 904.00 Mn |
| Jun 30, 2022 | 912.00 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 933.00 Mn |